Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: A possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy

Cell Biology International

Volumn 22, Issue 2, 1998, Pages 95-103

  Mor Vaknin, Nirit ^a   Turgeman, Hava ^a   Torgeman, Amram ^a   Wolfson, Marina ^a   Huleihel, Mahmoud ^a   Aboud, Mordechai ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Astrocytes; Blood brain barrier; CNS; HTLV I; Syncytium; TSP HAM

Indexed keywords

ENVELOPE PROTEIN; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MACROPHAGE; MOUSE; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; SYNCYTIUM; T LYMPHOCYTE;

ANIMALIA; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; LEUKAEMIA VIRUS; RNA VIRUSES;

EID: 0032412082     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1998.0241     Document Type: Article

References (47)

1. Aboud M, Golde D-W, Berch N, Rosenblatt J-D, Chen I-S-Y. A colony assay for in-vitro transformation by human T-cell leukemia virus type-I and type-II. Blood. 70:1987;432-436.
2. Aboud M, Dombrovsky A, Rosner M, Feldman G, Revazova T, Strilitz-Hassan Y, Priel E, Wolfson M, Segal S, Flügel R-M. Regulatory elements and leukemogenicity of HTLV-I and HTLV-II. J Viral Dis. 1:1993;31-49.
3. Akizuki S, Nakazato O, Higuchi Y, Tanabe K, Setoguchi M, Yoshida S, Miyazaki Y, Yamamoto S, Subou S, Sannomiya K, Okajima T. Necroscopy findings in HTLV-I associated myelopathy. Lancet. i:1987;156-157.
4. Bigner D-D, Bigner S-H, Pontén J, Westermark M-S, Mahaley M-S Jr, Ruoslahti E, Herschman H, Eng L-F, Wikstrand C-J. Heterogeneity of genotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol. 40:1981;201-229.
5. Buckle G-J, Hafler D-A, Holsberg P. HTLV-I induced T-cell activation. J Acquir Immune Defic Syndr Hum Retrovirol (Suppl. 1). 13:1996;S107-S113.
6. Cann A-J, Chen S-Y. Human T-cell leukemia virus type-I and II. Fields Virology, 3rd edition. Vol. 2. Chapter 52. 1996;Lippincott-Raven Publishers, Philadelphia-New York. p. 1849-1880.
7. Ceroni M, Piccardo P, Rogers-Johnson P, Mora C, Asher D-M, Gajdusek C, Gibbs C-J. Intrathecal synthesis of IgG antibodies to HTLV-I supports an etiological role for HTLV-I in tropical spastic paraparesis. Ann Neurol (Suppl.). 23:1988;S188-S191.
8. Chlichlia K, Moldenhauer G, Daniel P-T, Busslinger M, Gazzolo L, Schirrmacher V, Khazaie K. Immediate effects of reversible HTLV-I tax function. T-cell activation and apoptosis. Oncogene. 10:1995;269-277.
9. Delamarre L, Pique C, Phan D, Tusz T, Dokhelar M-C. Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein. J Virol. 68:1994;3544-3549.
10. Gessain A, Saal F, Gout O, Daniel M-T, Flandrin G, De Thé G, Peries J, Sigaux F. High human T-lymphotropic virus type-I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells in French West Indian Guinness and African patients with tropical spastic paraparesis. Blood. 75:1990;428-433.
11. Gessain A, Louie A, Gout O, Gallo R-C, Franchini G. Human T-cell leukemia virus type-I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I associated myelopathy. J Virol. 65:1991;1628-1633.
12. Greenberg S-J. Human retroviruses and demyelinating diseases. Neurol Clinics. 13:1995;75-97.
13. Hara H. Autoimmune mechanism in HAM/TSP. Nippon Rinsh. 52:1994;2919-2925.
14. Hertz L, McFarlin D-E, Waksman B-H. Astrocytes: Auxiliary cells for immune response in central nervous system. Immunol Today. 11:1990;265-268.
15. Hirayama M, Miyadai T, Yokochi T, Sato K, Kubota T, Iida M, Fujiki N. Infection of human T-lymphotropic virus type-I to astrocytes in vitro with induction of class II major histocompatibility complex. Neurosci Lett. 92:1988;34-39.
16. Itoyama Y, Kira J, Fujii N, Goto I, Yamamoto N. Increases in the helper inducer T-cells and activated T-cells in HTLV-I associated myelopathy. Ann Neurol. 26:1989;257-263.
17. Iwasak I. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci. 96:1990;103-123.
18. Jacobson S, Raine C-S, Mingioli E-S, McFarlin D-E. Isolation of an HTLV-I like retrovirus from patients with tropical spastic paraparesis. Nature (Lond). 331:1988;540-543.
19. Jacobson S, Zaninovic V, Mora M, Rodgers-Johnson P, Sheremata W-A, Gibbs C-J. Jr, Gajdusek D-C, McFarlin D-E. Immunological findings in neurological disease associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic paraparesis. Ann Neurol (Suppl.). 23:1988b;S196-S200.
20. +. Nature (Lond). 348:1990;245-348.
21. Jacobson S, McFarlin D-E, Robinson S, Voskuhl R, Martin R, Brewah A, Newell A-J, Koenig S. Demonstration of HTLV-I specific cytotoxic T-lymphocytes in the cerebrospinal fluid of patients with HTLV-I associated neurological disease. Ann Neurol. 32:1992;651-657.
22. Jon T, Fujita M, Tanaka Y, Shiku H. Preparation of a murine cell line which stably expresses human T-lymphotropic virus type-I (HTLV-I) env genome products. Gene. 161:1995;227-230.
23. Kinoshita T, Shimoyama M, Tobinai K, Ito M, Ito S-I, Ikeda S, Tajima K, Shimotohno K, Sugimura T. Detection of mRNA for thetaxrex. Proc Natl Acad Sci USA. 86:1989;5620-5624.
24. Kira J, Koyanagi Y, Yamada T, Itoyama I, Goto N, Yamamoto H, Sasaki H, Sakaki Y. Increased HTLV-I proviral DNA in HTLV-I associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol. 29:1991;194-201.
25. Lehky T-J, Fox C-H, Koenig S, Levin M-C, Flerlage N, Izumo S, Sato E, Rain C-S, Osame M, Jacobson S. Detection of human T-lymphotropic virus type-I (HTLV-I)tax. Ann Neurol. 37:1995;167-175.
26. Leno M, Simpson R-M, Bowers F-S, Kindt T-J. Human T-lymphocyte virus 1 from leukemogenic cell line mediates in vivo and in vitro lymphocyte apoptosis. J Exp Med. 181:1995;1575-1580.
27. Li Q-X, Camerini D, Xie Y, Greenwald M, Kuritzkes D-R, Chen I-S. Syncytium formation by recombinant HTLV-II envelope glycoprotein. Virology. 218:1996;279-284.
28. Luciw P-A. Human immunodeficiency viruses and their replication. Fields B-N, Knipe D-M. Fields Virology, 3rd edition. Vol. 2. Chapter 60. 1996;1881-1952 Lippincott-Raven Publishers, Philadelphia.
29. Matsumoto M, Sugimoto M, Nakashima H, Imamura F, Kawano O, Uyama E, Takatsu K, Akari S. Spontaneous proliferation and release of soluble interleukin-2 receptors in patients with HTLV-I associated myelopathy. Am J Trop Med Hyg. 42:1990;365-373.
30. Moore G-R-W, Traugott U, Scheinberg L-C, Raine C-S. Tropical spastic paraparesis: a model of virus-induced cytotoxic T-cell mediated demyelination. Ann Neurol. 26:1989;523-530.
31. Moritoyo T, Reinhart T-A, Moritoyo H, Sato E, Izumo S, Osame M, Haase A-T. Human T-lymphotropic virus type-I associated myelopathy and tax gene expression in CD4+ T-lymphocytes. Ann Neurol. 40:1996;84-90.
32. Nagy K, Weiss R-A, Clapham P, Cheingsong-Popov R. Biological properties of human T-cell leukemia virus envelope antigens. Gallo RC, Essex M, Gross L. Human Leukemia Viruses. 1984;121-131 Cold Spring Harbor Laboratory, Cold Spring Harbor.
33. Nishimura M, Adachi A, Aakiguchi I, Shirahata N, Maeda M, Ishimoto A, Mezaki T, Kimura J. High ratio of HTLV-I infected cells in HTLV-I associated myelopathy (HAM). Acta Neurol Scand. 81:1990;209-214.
34. Nishimura Y, Nakamura T, Ichinose K, Nagasato K, Ohishi K, Watanabe H, Shirabe S, Tsujihata M, Nagataki S. Antiproliferative factor against human gliomastoma cell line T98G identified in culture super-natants of CD4+ cells from patients with HTLV-I associated myelopathy. J Neurol Sci. 122:1994;214-219.
35. Osame M, Matsumoto M, Usuku K-S, Ijichi N, Amitani H, Tara M, Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type-I and adult T-cell leukemia-like cells. Ann Neurol. 21:1987;117-122.
36. Priel E, Hassan Y, Huleihel M, Segal S, Aboud M. Amplification of Moloney murine leukemia virus genome and its possible role in facilitating chemical carcinogenesis in normal rat kidney cells. J Gen Virol. 72:1991;2317-2320.
37. Revazova T, Dombrovsky A, Löchelt M, Flügel R-M, Aboud M. Tax-independent stimulation of human T-cell leukemia virus type-I expression and differentiation effects on its infectivity by subtoxic and toxic doses of 3-methylcholanthrene. Cell Mol Biol Res. 41:1995;377-385.
38. Sagara Y, Inoue Y, Shiraki H, Jino A, Hoshino H, Maeda Y. Identification and mapping of the functional domains on human T-cell lymphotropic virus type 1 envelope protein by using synthetic peptides. J Virol. 70:1996;1564-1569.
39. Tendler C-L, Greenberg S-J, Blattner W-A, Manns A, Murphy E, Fleisher T, Hanchard B, Morgan O, Burton J-D, Nelson D-L, Waldmann T-A. Transactivation of interleukin-2 and it receptor induces immune activation in human T-cell lymphotropic virus type-I associated myelo-pathy: Pathogenic implication and rational for immunotherapy. Proc Natl Acad Sci USA. 87:1990;5218-5222.
40. Terunuma H, Iwasaki Y, Tsukamoto T, Konno H, Yamamoto T, Ohara Y. Neurotoxic activity in HTLV-I carrier lymphocyte culture. J Neurol Sci. 92:1989;169-180.
41. Tsukamoto T, Iwasaki Y, Osame M, Usuku K, Igata A. Myelinotoxic activity of CSF from patients with HTLV-I associated myelopathy (HAM). Adv Neurol Sci (Tokyo). 31:1987;759-765.
42. Usuku K, Sonoda S, Osame M, Yashiki S, Takahashi K, Matsumoto M, Sawada T, Tsuji K, Tara M, Igara A. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I associated myelopathy: comparison with adult T-cell leukemia. Ann Neurol (Suppl.). 23:1988;S143-S142.
43. Weiss R-A, Clapham A-P, Nagy K, Hoshino H. Envelope properties of human T-cell leukemia viruses. Curr Top Microbiol Immunol. 115:1985;235-246.
44. Wekerle H, Linington C, Lassmann H, Meyermann R. Cellular immune reactivity within CNS. Trends Neurosci. 9:1986;271-277.
45. Wu E, Dickson D-W, Jacobson S, Raine C-S. Neuro-axonal dystrophy in tropical spastic paraparesis/HTLV-I associated myelopathy. Acta Neuropathol. 86:1993;224-235.
46. Yamada T, Yamaoko S, Goto T, Nakai M, Tsujimoto Y, Hatanaka M. The human T-cell leukemia virus tax protein induces apoptosis which is blocked by the bcl-2 protein. J Virol. 68:1994;3374-3379.
47. Yoshida M, Osame M, Kawai H, Toita M, Kuwasaki N, Nishida Y, Hiraki Y, Takahashi K, Nomura K, Sonoda S, Eiraku N, Ijichi S, Usuku K. Increased replication of HTLV-I in HTLV-I associated myelopathy. Ann Neurol. 26:1989;331-335.